# Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients

> **NCT01042236** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 22 (actual)

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **DRUG:** Fesoterodine

## Key facts

- **NCT ID:** NCT01042236
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2011-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01042236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01042236, "Evaluation Of The Ability Of Fesoterodine To Increase Urethral Pressure In Stress Urinary Incontinence Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01042236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*